Moving forward: cystic fibrosis gene therapy. (2013)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddt372
PubMed Identifier: 23918661
Publication URI: http://europepmc.org/abstract/MED/23918661
Type: Journal Article/Review
Volume: 22
Parent Publication: Human molecular genetics
Issue: R1
ISSN: 0964-6906